longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesLongbridge ProFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge

Merck

MRK

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
  • Weekly Recap | Merck +0.24%, outperforming the S&P 500 with defensive strength

    Weekly Review·Oct 17, 2026 at 07:42 AM
    MRK0.00%
  • Weekly Recap | Merck +0.9%, most brokers rate it buy

    Weekly Review·Oct 10, 2026 at 07:11 AM
    MRK0.00%
  • Weekly Recap | Merck -3.01%, most brokers rate it buy

    Weekly Review·Oct 3, 2026 at 07:18 AM
    MRK0.00%
  • Weekly Recap | Merck +1.3%, multiple drug wins

    Weekly Review·Sep 26, 2026 at 07:25 AM
    MRK0.00%
  • Weekly Recap | Merck +2.04%, most brokers rate it buy

    Weekly Review·Sep 19, 2026 at 06:23 AM
    MRK0.00%
  • Weekly Recap | Merck -4.26%, most brokers rate it buy

    Weekly Review·Sep 12, 2026 at 06:21 AM
    MRK0.00%
  • Weekly Recap | Merck +1.33%, most brokers rate it buy

    Weekly Review·Sep 5, 2026 at 07:25 AM
    MRK0.00%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy